Letter
Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products

https://doi.org/10.1016/j.anai.2020.11.009Get rights and content

Cited by (0)

Disclosures: The authors have no conflicts of interest to report.

Funding: The authors have no funding sources to report.

View Abstract